期刊文献+

2006~2008年我院H_2受体拮抗剂应用情况分析 被引量:1

Utilization Analysis of H_2-Receptor Blockers in Our Hospital During 2006~2008
下载PDF
导出
摘要 目的:了解我院2006~2008年的H2受体拮抗剂的使用状况及趋势。方法:采用药品金额排序法和限定日剂量法,对H2受体拮抗剂的品种、消耗量、销售金额、用药频度(DDDs)、日均费用(DDC)进行汇总、排序、分析。结果:H2受体拮抗剂整体使用量、DDC呈下降趋势。其中枸橼酸雷尼替丁DDDs有所上升,其他H2受体拮抗剂DDDs均逐年下降。结论:我院H2受体拮抗剂使用基本合理,H2受体拮抗剂所占份额逐年缩小,但仍有一定发展空间。 OBJECTIVE:To probe into the utilization of H2 receptor antagonists and its developmental tendency in our hospital during 2006 ~ 2008.METHODS:The utilization of H2-receptor blockers was analyzed in aspect of its variety,consumption quantity,consumption sum,defined daily dose(DDDs) and daily average cost(DDC) by applying the methods of order of consumption sum and defined daily dose by using the ordering of consumption sum and DDDs methohds.RESULTS:The overall consumption quantity and DDC of H2-receptor blockers showed a downward trend;however,the DDDs of Ranitidine Bismuth Citrate had some increase,whereas the DDDs of all the other H2receptor blockers showed a year-on-year decrease.CONCLUSION:The utilization of H2-receptor blockers in our hospital is basically reasonable,though with a decreasing market share,H2-receptor blockers still have some market development potential.
出处 《中国医院用药评价与分析》 2010年第4期312-314,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 H2受体拮抗剂 DDD DDDS DDC 用药金额 H2-receptor blockers DDD DDDs DDC Consumption sum
  • 相关文献

参考文献6

二级参考文献9

  • 1赵敬东.兰索拉唑治疗胃食管反流病的疗效观察[J].中国药师,2006,9(7):650-651. 被引量:10
  • 2梁小燕,高青.质子泵抑制剂的研发进展[J].医学综述,2007,13(4):245-247. 被引量:22
  • 3Blumen H. The interaction between PPI and orther drugs [ J]. Drug Safety ,2006,29(9) :769.
  • 4刘彤.质子泵抑制剂的药物相互作用.中国医药论坛报,2008,34(26):90-90.
  • 5Peghini PL, Katz PO, Bracy NA, et al. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors [ J].Am J Gastroenterol,1998 ,93 :763.
  • 6Peghini PL, Katz PO, Castell DO. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects [ J ]. Gastroenterology, 1998,115:1335.
  • 7Katsube T,Adachi K,Kawamura A,et al. Helicobacter pylori infection influences nocturnal gastric acid breakthrough [ J]. Aliment Pharmacol Ther,2000,14:1049.
  • 8Hirschowitz BI,Keeling D,Lewin M ,et al. Pharmacological aspects of acid secretion [J]. Dig Dis Sci,1995,40:3S.
  • 9Hatlebakk JG, Katz PO, Camacho LL, et al. Proton pump inhibitors better acid suppression when taken before a meal than without a meal [J]. Aliment Pharmacol Ther,2000,14:1267.

共引文献25

同被引文献4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部